BENGALURU, June 29 -- Honasa Consumer Ltd's acquisition of a majority stake in Fluence Pharma marks more than its entry into nutraceuticals. It is also a clear signal that India's beauty and personal care (BPC) brands are increasingly looking to healthcare and prescription-led segments to build consumer trust and unlock new avenues of growth, industry executives told Mint.

The Mamaearth parent said last week it will acquire a 58% stake in Mumbai-based Fluence Pharma at an enterprise value of around Rs.135 crore, and will purchase the remaining stake in phases over the next 5-7 years. Alongside the acquisition, the company is setting up a wholly-owned subsidiary, Honasa Health, to build a business-to-consumer nutraceuticals franchise.

Fl...